Karyopharm Therapeutics Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2009 | — | — | $-179.0K |
| FY2010 | — | — | $-2.2M |
| FY2011 | $152.0K | $-10.3M | $-10.3M |
| FY2012 | $634.0K | $-15.9M | $-15.9M |
| FY2013 | $387.0K | $-34.0M | $-33.9M |
| FY2014 | $229.0K | $-75.8M | $-75.8M |
| FY2015 | $250.0K | $-119.1M | $-118.2M |
| FY2016 | $154.0K | $-110.7M | $-109.6M |
| FY2017 | $1.6M | $-130.5M | $-129.0M |
| FY2018 | $30.3M | $-179.9M | $-178.4M |
| FY2019 | $40.9M | $-189.3M | $-199.6M |
| FY2020 | $108.1M | $-171.9M | $-196.3M |
| FY2021 | $209.8M | $-98.3M | $-124.1M |
| FY2022 | $157.1M | $-142.2M | $-165.3M |
| FY2023 | $146.0M | $-129.5M | $-143.1M |
| FY2024 | $145.2M | $-119.4M | $-76.4M |
| FY2025 | $146.1M | $-90.7M | $-196.0M |